ES2150152T3 - Nuevos derivados de esteres de nitrito/nitrato esteroideos utiles como farmacos antiinflamatorios. - Google Patents

Nuevos derivados de esteres de nitrito/nitrato esteroideos utiles como farmacos antiinflamatorios.

Info

Publication number
ES2150152T3
ES2150152T3 ES96943559T ES96943559T ES2150152T3 ES 2150152 T3 ES2150152 T3 ES 2150152T3 ES 96943559 T ES96943559 T ES 96943559T ES 96943559 T ES96943559 T ES 96943559T ES 2150152 T3 ES2150152 T3 ES 2150152T3
Authority
ES
Spain
Prior art keywords
inflammatory
pharmaces
ester derivatives
nitrate ester
derivatives useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96943559T
Other languages
English (en)
Inventor
Foe S Tjoeng
Mark G Currie
Mark E Zupec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of ES2150152T3 publication Critical patent/ES2150152T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS DERIVADOS DE ESTER DE NITRATO/NITRITO DE ESTEROIDES Y A SU UTILIZACION PARA EL TRATAMIENTO DE ENFERMEDADES ANTIINFLAMATORIAS.
ES96943559T 1995-12-08 1996-12-06 Nuevos derivados de esteres de nitrito/nitrato esteroideos utiles como farmacos antiinflamatorios. Expired - Lifetime ES2150152T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/569,812 US5707984A (en) 1995-12-08 1995-12-08 Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs

Publications (1)

Publication Number Publication Date
ES2150152T3 true ES2150152T3 (es) 2000-11-16

Family

ID=24276970

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96943559T Expired - Lifetime ES2150152T3 (es) 1995-12-08 1996-12-06 Nuevos derivados de esteres de nitrito/nitrato esteroideos utiles como farmacos antiinflamatorios.

Country Status (12)

Country Link
US (1) US5707984A (es)
EP (1) EP0873351B1 (es)
JP (1) JP2000501732A (es)
AT (1) ATE195128T1 (es)
AU (1) AU1277297A (es)
CA (1) CA2239910A1 (es)
DE (1) DE69609632T2 (es)
DK (1) DK0873351T3 (es)
ES (1) ES2150152T3 (es)
GR (1) GR3034337T3 (es)
PT (1) PT873351E (es)
WO (1) WO1997021721A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
IT1311922B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
US6765019B1 (en) 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
EP2067784A3 (en) * 2000-08-05 2012-08-22 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
WO2002088167A1 (en) * 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
ATE399174T1 (de) * 2001-06-12 2008-07-15 Glaxo Group Ltd Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
AU2003278565A1 (en) * 2002-10-25 2004-05-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
WO2010147742A2 (en) 2009-06-18 2010-12-23 Theravasc Inc. Use of nitrite salts in treating tissue damage
CN105399792A (zh) * 2015-12-07 2016-03-16 西宁意格知识产权咨询服务有限公司 一种新的甾体类化合物及其制备方法和医药用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3215713A (en) * 1960-04-04 1965-11-02 Schering Corp Steroid nitrite esters
US3298941A (en) * 1961-05-29 1967-01-17 Schering Corp Photochemical process for rearranging organic hypohalite and nitrite compounds
GB1082573A (en) * 1965-02-12 1967-09-06 Boots Pure Drug Co Ltd Improvements in the preparation of steroid esters
US3639434A (en) * 1967-02-02 1972-02-01 Boots Pure Drug Co Ltd 17-acyloxysteroids and their manufacture
DE1643036B2 (de) * 1967-08-16 1976-04-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 11 beta-halogensteroide, diese enthaltende arzneimittel sowie verfahren zu ihrer herstellung
HU164115B (es) * 1971-05-07 1973-12-28
HU163145B (es) * 1971-09-23 1973-06-28
DE2236115A1 (de) * 1972-07-20 1974-02-07 Schering Ag Verfahren zur herstellung von delta hoch 4.9(11).16 -3.20diketosteroiden
GB1446126A (en) * 1974-05-16 1976-08-18 Res Inst For Medicine Chemistr Photolytic preparation of diol mononitrates
ATE172183T1 (de) * 1992-07-30 1998-10-15 Cal Int Ltd Ester und kombinationen von einem organischen nitrat und einem salicyclat

Also Published As

Publication number Publication date
EP0873351B1 (en) 2000-08-02
DE69609632D1 (de) 2000-09-07
GR3034337T3 (en) 2000-12-29
WO1997021721A1 (en) 1997-06-19
US5707984A (en) 1998-01-13
EP0873351A1 (en) 1998-10-28
CA2239910A1 (en) 1997-06-19
DE69609632T2 (de) 2000-11-09
DK0873351T3 (da) 2000-10-23
ATE195128T1 (de) 2000-08-15
PT873351E (pt) 2001-01-31
JP2000501732A (ja) 2000-02-15
AU1277297A (en) 1997-07-03

Similar Documents

Publication Publication Date Title
GR3034337T3 (en) Novel steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
PT839154E (pt) Peptidos e composicoes biologicamente activos sua utilizacao
ES2150705T3 (es) Derivados de ester de nitrito esteroideos utiles como farmacos antiinflamatorios.
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
AP1422A (en) 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent.
AU3887797A (en) Pentafluorobenzenesulfonamides and analogs
PT929565E (pt) Esteres de nitrato de compostos corticoides e suas aplicacoes farmaceuticas
AU5246596A (en) Compounds as intermediates
AU5377698A (en) Substituted pyrrolyl compounds for the treatment of inflammation
PA8432901A1 (es) Compuestos de piridilpirrol
FI910222A0 (fi) Anti-inflammatoriska 4-aminofenolderivat.
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
PT912185E (pt) Novas formulacoes farmaceuticas contendo derivados de ester nitrato de esteroides proveitosos como farmacos anti-inflamatorios
NZ330244A (en) Isoxazole derivatives useful in the treatment of inflammatory diseases
DE60016181D1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
NZ332775A (en) Polyol succinates and their pharmaceutical formulation
ES2144993T3 (es) Beta-dicetonas sustituidas y su uso en el tratamiento de enfermedades inflamatorias del intestino.
ES2073919T3 (es) Derivados de piperidina 1,3,4-trisubstituidos, su obtencion y empleo.
DE69328205D1 (de) Rektale Flunisolid-Zubereitung zur Behandlung entzündlicher Darmerkrankungen
ES2106858T3 (es) Nuevos derivados de la citarabina, su procedimiento de preparacion y su uso contra enfermedades cancerosas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 873351

Country of ref document: ES